고속 액체 크로마토그래피 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

High-performance Liquid Chromatography Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories, Software), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,275,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,666,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,447,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

고속 액체 크로마토그래피 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 고속 액체 크로마토그래피 세계 시장 규모는 2025-2030년 동안 CAGR 6.0%로 2030년까지 70억 3,000만 달러에 달할 것으로 예상됩니다.

제약 생산의 급격한 성장, 의약품 순도에 대한 엄격한 규제 기준, 진단 및 연구 목적의 고속 액체 크로마토그래피(HPLC) 기술 채택 증가가 시장을 주도하고 있습니다.

HPLC는 일반적으로 산업 규모에서 약물의 순도 평가에 사용됩니다. 또한 신약 후보로 탐색 중인 분자의 특성 평가도 가능합니다. 이 기술에 대한 수요는 의약품 유효 성분의 일관성 확보 및 복용량 결정에 대한 용도가 증가함에 따라 확대될 것으로 예상됩니다. 또한, 이 기술은 제약 산업에서 중요한 품질 특성 충족을 보장하기 위한 품질 관리 검사에도 중요한 의미를 지닙니다.

이 기술은 개선된 고정식 및 환자 시료의 연속 분석에 도움이 되는 다중 채널 HPLC 장비를 사용할 수 있게 됨에 따라 임상 진단 서비스를 향상시키고 있습니다. 이러한 특성은 낮은 처리량 또는 중간 처리량 실험실에 바람직하며 빠른 처리 시간을 가능하게 합니다. 마찬가지로, 최근 컬럼 기술 동향은 HPLC 작업의 효율성을 높이고 있으며, 이는 시장 성장을 촉진할 가능성이 높습니다. 예를 들어, 2μm 이상의 표면 다공성 실리카 입자의 출현으로 상대적으로 낮은 배압과 짧은 컬럼을 사용하여 HPLC 작동이 개선되었습니다.

또한, 이 시장에 참여하는 기업들은 이 기술의 확장된 적용 범위에 대응하기 위해 새로운 HPLC 기반 분석기 및 시스템을 출시하고 있습니다. 예를 들어, 2021년 6월 Trivitron Healthcar는 HbA1c와 Hb 변종을 3분 이내에 검출하는 것을 목표로 하는 새로운 HPLC 분석기인 NANO H5 &NANO H110을 출시했습니다.

또한, COVID-19 팬데믹으로 인해 새로운 치료법, 백신 및 신뢰할 수 있는 진단법 개발에 HPLC 시스템의 도입이 가속화되고 있습니다. 또한, SARS-CoV-2 바이러스의 새로운 변종으로 인해 바이러스 단백질의 특성 분석을 위한 이 기술의 역학적 적용이 증가할 것으로 예상됩니다. 이러한 요인들은 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

고속 액체 크로마토그래피 시장 보고서 하이라이트

• 제품별로는 통합형 HPLC 시스템의 우위와 첨단 검출기의 가용성 증가로 인해 기기 부문이 2024년 48.2%의 가장 큰 매출 점유율을 차지했습니다.
• 용도별로는 임상 연구 애플리케이션이 2024년 40.7%로 가장 큰 매출 점유율을 차지했습니다. 이러한 성장은 임상 검사 활동의 범위 확대, 바이오의약품 연구 및 개발 증가, 고성능 분석 기술에 대한 수요 증가와 관련이 있습니다.
• 최종 용도별로는 제약 및 생명공학 기업이 2024년 41.9%의 점유율을 차지하며 시장을 장악했습니다. 이들 기업은 품질 관리, 의약품 순도 측정, 의약품 후보 화합물 특성 평가, 의약품 활성 성분의 안정성 평가 등 다양한 용도로 HPLC 분석법을 채택하고 있습니다.
• 북미 시장은 2024년 매출 점유율 31.68%를 차지하며 전체 세계 시장을 지배했습니다.
• 아시아태평양 시장은 의료 인프라와 기술 혁신에 힘입어 빠르게 성장하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 고속 액체 크로마토그래피 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 고속 액체 크로마토그래피 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 고속 액체 크로마토그래피 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 고속 액체 크로마토그래피 시장 : 제품 변동 분석
• 고속 액체 크로마토그래피 시장 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 기기
  • HPLC 시스템
  • 펌프
  • 검출기
  • 기타
• 소모품과 부속품
  • 칼럼
  • 필터
  • 바이알
  • 튜브
  • 기타
• 소프트웨어

제5장 고속 액체 크로마토그래피 시장 : 용도별, 추정·동향 분석

• 부문 대시보드
• 고속 액체 크로마토그래피 시장 : 용도 변동 분석
• 고속 액체 크로마토그래피 시장 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 임상 연구 용도
• 진단 용도
• 법의학 용도
• 기타

제6장 고속 액체 크로마토그래피 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 고속 액체 크로마토그래피 시장 : 최종 용도 변동 분석
• 고속 액체 크로마토그래피 시장 최종 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 제약·바이오테크놀러지 기업
• 학술연구기관
• 기타

제7장 고속 액체 크로마토그래피 시장 : 지역별, 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 상황

• 시장 진출 기업 분류
• 주요 시장 진출 기업의 최근 동향과 영향 분석
• 기업 시장 점유율 분석, 2024년
• 주요 기업 개요
  • WATERS CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • AGILENT TECHNOLOGIES, INC
  • SHIMADZU CORPORATION
  • SARTORIUS AG
  • PERKINELMER, INC
  • BIO-RAD LABORATORIES, INC
  • MERCK KGAA
  • TOSOH BIOSCIENCE GMBH
  • DANAHER CORPORATION

ksm

영문 목차

영문목차

High-performance Liquid Chromatography Market Growth & Trends:

The global high-performance liquid chromatography market size is expected to reach USD 7.03 billion by 2030, registering a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rapid growth in pharmaceutical production, stringent regulatory norms for drug purity, and increasing adoption of high-performance liquid chromatography (HPLC) techniques for diagnostics and research purposes are driving the market.

HPLC is commonly used for the assessment of drug purity on an industrial scale. It also enables characterization of molecules being explored as potential new drug candidates. Demand for the technique is anticipated to grow due to its increasing applications in ensuring consistency and determination of dosage of active pharmaceutical ingredients. Furthermore, the technique holds significance in quality control testing for assuring the fulfillment of critical quality attributes in the pharmaceutical industry.

The technique is augmenting clinical diagnostic services due to the availability of improved stationary phase alternatives and multiple channel HPLC instruments that can aid in sequential analysis of patient samples. Such attributes are desirable for low- or moderate-throughput laboratories and enable faster turnaround times. Similarly, recent developments in column technologies are increasing the efficiency of HPLC operations and are likely to fuel the market growth. For instance, the advent of>2-µm superficially porous silica particles has led to improved HPLC operations at comparatively lower back-pressure and with the use of shorter columns.

Furthermore, companies involved in the market are launching new HPLC-based analyzers and systems for capitalizing on the expanding scope of applications for the technique. For instance, in June 2021, Trivitron Healthcare launched two new HPLC analyzers, NANO H5 & NANO H110, intended for the detection of HbA1c and Hb variants in less than three minutes.

In addition, the COVID-19 pandemic has accelerated the adoption of HPLC systems for the development of new therapeutics, vaccines, and reliable diagnostic methods for the disease. Furthermore, epidemiological applications of the technique for the characterization of viral proteins are expected to gain traction due to the emerging mutations of the SARS-CoV-2 virus. These factors are anticipated to positively affect the market growth.

High-performance Liquid Chromatography Market Report Highlights:

• By product, the instruments segment held the largest revenue share of 48.2% in 2024 due to the increasing dominance of integrated HPLC systems and the availability of advanced detectors.
• Based on application, Clinical research applications accounted for the largest revenue share of 40.7% in 2024. This growth can be linked to the increasing scope of clinical trial activities, a rise in biopharmaceutical research and development, and a growing demand for high-throughput analytical techniques.
• By end-user, pharmaceutical and biotechnology companies dominated the market and accounted for 41.9% share in 2024. Within these companies, HPLC methods are employed for various applications, including quality control, drug purity determination, characterization of drug candidates, and evaluation of the stability of active ingredients in pharmaceuticals.
• The North America market dominated the overall global market and accounted for the 31.68% of revenue share in 2024.
• The Asia Pacific market is experiencing the fastest growth, driven by significant innovations in healthcare infrastructure and technology.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. High-performance Liquid Chromatography Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements In HPLC Systems
    • 3.2.1.2. Increasing Adoption Of HPLC Techniques In The Pharmaceutical Industry
    • 3.2.1.3. Increasing Availability Of HPLC Method Development Systems And Support Software
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Instrumentation Costs
    • 3.2.2.2. Lack of Skilled Personnel
• 3.3. High-performance Liquid Chromatography Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. High-performance Liquid Chromatography Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. High-performance Liquid Chromatography Market: Product Movement Analysis
• 4.3. High-performance Liquid Chromatography Market by Product Outlook (USD Billion)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Instruments
  • 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5.2. HPLC Systems
    • 4.5.2.1. HPLC Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5.3. Pumps
    • 4.5.3.1. Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5.4. Detectors
    • 4.5.4.1. Detectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.6. Consumables & Accessories
  • 4.6.1. Consumables & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6.2. Columns
    • 4.6.2.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2.2. Reverse-phase HPLC columns
      • 4.6.2.2.1. Reverse-phase HPLC columns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2.3. Normal-phase HPLC columns
      • 4.6.2.3.1. Normal-phase HPLC columns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2.4. Ion exchange HPLC columns
      • 4.6.2.4.1. Ion exchange HPLC columns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2.5. Size exclusion HPLC columns
      • 4.6.2.5.1. Size exclusion HPLC columns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.6.2.6. Other HPLC columns
      • 4.6.2.6.1. Other HPLC columns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6.3. Filters
    • 4.6.3.1. Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6.4. Vials
    • 4.6.4.1. Vials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6.5. Tubes
    • 4.6.5.1. Tubes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6.6. Others
    • 4.6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 4.7. Software
  • 4.7.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. High-performance Liquid Chromatography Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. High-performance Liquid Chromatography Market: Application Movement Analysis
• 5.3. High-performance Liquid Chromatography Market by Application Outlook (USD Billion)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Clinical Research Applications
  • 5.5.1. Clinical Research Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Diagnostic Applications
  • 5.6.1. Diagnostic Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.7. Forensic Applications
  • 5.7.1. Forensic Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.8. Other Applications
  • 5.8.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. High-performance Liquid Chromatography Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. High-performance Liquid Chromatography Market: End Use Movement Analysis
• 6.3. High-performance Liquid Chromatography Market by End Use Outlook (USD Billion)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Pharmaceutical & Biotechnology Companies
  • 6.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.6. Academic & Research Institutes
  • 6.6.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. High-performance Liquid Chromatography Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Recent Developments & Impact Analysis by Key Market Participants
• 8.3. Company Market Share Analysis, 2024
• 8.4. Key Company Profiles
  • 8.4.1. WATERS CORPORATION
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. THERMO FISHER SCIENTIFIC, INC.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. AGILENT TECHNOLOGIES, INC
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. SHIMADZU CORPORATION
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. SARTORIUS AG
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. PERKINELMER, INC
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. BIO-RAD LABORATORIES, INC
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. MERCK KGAA
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. TOSOH BIOSCIENCE GMBH
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. DANAHER CORPORATION
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives

관련자료